Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of antibody effector function by hinge domain engineering

Modulation of antibody effector function by hinge domain engineering

US Patent 8697396 · Granted Apr 15, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapies using anti-pseudomonas PSL and PCRV binding molecules2025
Molecules with altered neonate Fc receptor binding having enhanced therapeutic a2023
ILT7 binding molecules and methods of using the same2023
Antibodies directed against Staphylococcus aureus leukotoxins2023
Antibodies specific for IL-21 and uses thereof2022
Binding molecules specific for CD73 and uses thereof2022
Polynucleotides encoding antibodies or antigen binding fragments thereof that bi2021
Combinations of anti-Staphylococcus aureus antibodies2021
ILT7 binding molecules and methods of using the same2021
Antibodies directed against Staphylococcus aureus leukotoxins2021
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules2020
Antibodies specific for IL-21 and uses thereof2020